| Gene symbol | CD7 | Synonyms | GP40, LEU-9, TP41, Tp40 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17q25.3 | dbXrefs | |
| Description | CD7 molecule | ||||
| GTO ID | GTC3483 |
| Trial ID | NCT05909527 |
| Disease | T-Cell Large Granular Lymphocyte Leukemia |
| Altered gene | CD7 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD7 CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma |
| Year | 2023 |
| Country | China |
| Company sponsor | Guangzhou Bio-gene Technology Co., Ltd |
| Other ID(s) | BG-CT-22-004 |
| Cohort 1 | |||||||||||
|
|||||||||||